- Hong Kong
- /
- Life Sciences
- /
- SEHK:2228
XtalPi Holdings Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
XtalPi Holdings (HKG:2228) Full Year 2024 Results
Key Financial Results
- Revenue: CN¥266.4m (up 53% from FY 2023).
- Net loss: CN¥1.52b (loss narrowed by 21% from FY 2023).
- CN¥0.79 loss per share (improved from CN¥3.96 loss in FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
XtalPi Holdings Revenues Beat Expectations, EPS Falls Short
Revenue exceeded analyst estimates by 9.3%. Earnings per share (EPS) missed analyst estimates.
The primary driver behind last 12 months revenue was the Intelligent Automation Solutions segment contributing a total revenue of CN¥162.8m (61% of total revenue). Notably, cost of sales worth CN¥143.0m amounted to 54% of total revenue thereby underscoring the impact on earnings. The most substantial expense, totaling CN¥801.8m were related to Non-Operating costs. This indicates that a significant portion of the company's costs is related to non-core activities. Explore how 2228's revenue and expenses shape its earnings.
Looking ahead, revenue is forecast to grow 46% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Life Sciences industry in Hong Kong.
Performance of the Hong Kong Life Sciences industry.
The company's shares are down 13% from a week ago.
Risk Analysis
We don't want to rain on the parade too much, but we did also find 2 warning signs for XtalPi Holdings that you need to be mindful of.
If you're looking to trade XtalPi Holdings, open an account with the lowest-cost platform trusted by professionals, Interactive Brokers.
With clients in over 200 countries and territories, and access to 160 markets, IBKR lets you trade stocks, options, futures, forex, bonds and funds from a single integrated account.
Enjoy no hidden fees, no account minimums, and FX conversion rates as low as 0.03%, far better than what most brokers offer.
Sponsored ContentNew: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SEHK:2228
XtalPi Holdings
An investment holding company, provides drug discovery and intelligent automation solutions in China, the United States, Europe, South Korea, and Japan.
Adequate balance sheet with limited growth.
Market Insights
Community Narratives

